Jane Street Group, LLC Abb Vie Inc. Call Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $211 Million - $257 Million	1,288,200 New	1,288,200 $254 Million
Q1 2022 May 17, 2022	SELL	$131.98 - $163.75 $104 Million - $130 Million	-791,400 Reduced 35.27%	1,452,500 $235 Million
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $174 Million - $220 Million	1,620,600 Added 260.0%	2,243,900 $304 Million
Q3 2021 Nov 16, 2021	SELL	$106.4 - $120.78 $28.4 Million - $32.2 Million	-266,800 Reduced 29.97%	623,300 $67.2 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $26.9 Million - $30 Million	256,000 Added 40.37%	890,100 $100 Million
Q1 2021 May 18, 2021	SELL	$102.3 - $112.62 $29.9 Million - $32.9 Million	-292,200 Reduced 31.54%	634,100 $68.6 Million
Q4 2020 Feb 17, 2021	SELL	$80.49 - $108.67 $708,312 - $956,296	-8,800 Reduced 0.94%	926,300 $99.3 Million
Q3 2020 Nov 17, 2020	SELL	$85.91 - $100.83 $8.03 Million - $9.43 Million	-93,500 Reduced 9.09%	935,100 $81.9 Million
Q2 2020 Aug 17, 2020	BUY	$73.37 - $98.18 $6.9 Million - $9.23 Million	94,000 Added 10.06%	1,028,600 $101 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $174,150 - $264,033	2,700 Added 0.29%	934,600 $71.2 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $4.11 Million - $5.14 Million	57,000 Added 6.52%	931,900 $82.5 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $11.6 Million - $14 Million	184,800 Added 26.78%	874,900 $66.2 Million
Q2 2019 Aug 15, 2019	BUY	$65.7 - $83.98 $32.7 Million - $41.8 Million	497,400 Added 258.12%	690,100 $50.2 Million
Q1 2019 May 16, 2019	SELL	$77.14 - $90.79 $2.45 Million - $2.88 Million	-31,700 Reduced 14.13%	192,700 $15.5 Million
Q4 2018 Feb 15, 2019	BUY	$77.85 - $96.01 $4.28 Million - $5.28 Million	55,000 Added 32.47%	224,400 $20.7 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $5.43 Million - $6.04 Million	61,100 Added 56.42%	169,400 $16 Million
Q2 2018 Aug 15, 2018	SELL	$89.78 - $106.23 $19.1 Million - $22.6 Million	-213,100 Reduced 66.3%	108,300 $10 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $16.6 Million - $22.2 Million	180,500 Added 128.11%	321,400 $30.4 Million
Q4 2017 Feb 15, 2018	SELL	$89.56 - $98.21 $4.33 Million - $4.75 Million	-48,400 Reduced 25.57%	140,900 $13.6 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $13.2 Million - $16.9 Million	189,300	189,300 $16.8 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account